Upcoming event

Game changing session: NIMBUS trial

2020-07-27

Dr. Black (CA) discusses “Recurrence risk in patients with High Grade Non-Muscle Invasive Bladder Carcinoma in the Randomised Phase III Clinical Trial ‘NIMBUS’ stratified for EORTC and CUETO risk categories. A contemporary trend to less recurrences?”